Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $418.77 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $131.10 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $124.00 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $52.72 | 2 | $0 (2023) |
| ABBVIE INC. | $49.75 | 3 | $0 (2024) |
| Lilly USA, LLC | $33.80 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $14.20 | 1 | $0 (2022) |
| Phadia US Inc. | $13.20 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.43 | 1 | ABBVIE INC. ($16.43) |
| 2023 | $315.22 | 6 | AstraZeneca Pharmaceuticals LP ($131.10) |
| 2022 | $87.12 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($25.43) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $124.00 | General |
| 05/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: DIABETES | ||||||
| 03/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Diabetes | ||||||
| 02/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), BREZTRI | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $119.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: DIABETES | ||||||
| 08/30/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Diabetes | ||||||
| 07/26/2022 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $13.20 | General |
| Category: Allergy/Immunology | ||||||
| 03/07/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 51 | 66 | $10,275 | $4,001 |
| 2022 | 3 | 86 | 121 | $18,655 | $5,733 |
| 2021 | 3 | 64 | 98 | $15,950 | $5,971 |
| 2020 | 1 | 26 | 36 | $7,000 | $2,283 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 41 | $5,125 | $1,678 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $2,550 | $1,283 | 50.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 13 | $2,600 | $1,041 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 61 | $12,200 | $3,551 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 49 | $6,125 | $2,016 | 32.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 11 | 11 | $330.00 | $165.88 | 50.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 40 | $7,738 | $2,620 | 33.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 47 | $5,875 | $2,118 | 36.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $2,338 | $1,233 | 52.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 36 | $7,000 | $2,283 | 32.6% |
About Jazmine Garcia, NURSE PRACTITIONER
Jazmine Garcia, NURSE PRACTITIONER is a Family healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/19/2019. The National Provider Identifier (NPI) number assigned to this provider is 1396201018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jazmine Garcia, NURSE PRACTITIONER has received a total of $418.77 in payments from pharmaceutical and medical device companies, with $16.43 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($418.77).
As a Medicare-enrolled provider, Garcia has provided services to 227 Medicare beneficiaries, totaling 321 services with total Medicare billing of $17,988. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Clermont, FL
- Active Since 02/19/2019
- Last Updated 10/16/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1396201018
Products in Payments
- FARXIGA (Drug) $131.10
- JARDIANCE (Drug) $52.72
- MOUNJARO (Drug) $33.80
- QULIPTA (Drug) $32.76
- UBRELVY (Drug) $16.99
- ENTRESTO (Drug) $14.20
- ImmunoCAP (Device) $13.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Clermont
Mrs. Chantal Baptiste, Aprn, APRN
Family — Payments: $13,695
Ashlee Koronka, Aprn, APRN
Family — Payments: $7,969
Jessica Bean, Arnp, ARNP
Family — Payments: $5,976
Mrs. Narissa Seelall, Aprn, APRN
Family — Payments: $5,676
Tammy Covington, Np-C, NP-C
Family — Payments: $5,500
Chelsea Merrow, Aprn, APRN
Family — Payments: $5,044